MAXCYTE INC. - COMMON
3.5500
29-11月-24 13:45:00
15 分の遅延
株式
+0.0300
+0.85%
本日の幅
3.4600 - 3.6150
ISIN
N/A
ソース
NASDAQ
-
12 4 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year Financial Results
22 3 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
MaxCyte, Inc. Names Cenk Sumen Chief Scientific Officer
09 3 2022 16:15:00 提供 Nasdaq GlobeNewswire
-
MaxCyte to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022
24 2 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
14 2 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 2 2022 17:00:00 提供 Nasdaq GlobeNewswire
-
01 2 2022 02:00:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Announces Strong Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue Results
24 1 2022 02:30:00 提供 Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
12 11 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
MaxCyte Reports Third Quarter Financial Results
10 11 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Board Member Richard Douglas, PhD, Appointed Chairman of the Board
03 11 2021 09:00:02 提供 Nasdaq GlobeNewswire
-
29 10 2021 12:40:00 提供 Nasdaq GlobeNewswire
-
28 10 2021 10:00:00 提供 Nasdaq GlobeNewswire
-
MaxCyte to Report Third Quarter 2021 Financial Results on November 10, 2021
25 10 2021 16:30:00 提供 Nasdaq GlobeNewswire
-
MaxCyte Set to Join Russell 2000® Index
17 9 2021 08:35:00 提供 Nasdaq GlobeNewswire
-
13 9 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2021 Financial Results on September 13, 2021
02 9 2021 08:05:00 提供 Nasdaq GlobeNewswire